Skip to main content

FDA authorizes Novavax COVID booster for adults

The Food and Drug Administration authorized the Novavax COVID-19 vaccine as a booster for use in adults on Wednesday. The company has struggled with vaccine sales.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.